Target Price | $237.81 |
Price | $223.61 |
Potential |
6.35%
register free of charge
|
Number of Estimates | 16 |
16 Analysts have issued a price target CME Group a 2025 .
The average CME Group a target price is $237.81.
This is
6.35%
register free of charge
$275.00
22.98%
register free of charge
$181.00
19.06%
register free of charge
|
|
A rating was issued by 20 analysts: 8 Analysts recommend CME Group a to buy, 9 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CME Group a stock has an average upside potential 2025 of
6.35%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion $ | 5.58 | 6.12 |
11.15% | 9.77% | |
EBITDA Margin | 67.90% | 70.30% |
0.88% | 3.53% |
15 Analysts have issued a sales forecast CME Group a 2024 . The average CME Group a sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an CME Group a EBITDA forecast 2024. The average CME Group a EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 8.86 | 9.82 |
19.73% | 10.84% | |
P/E | 22.76 | |
EV/Sales | 13.31 |
7 Analysts have issued a CME Group a forecast for earnings per share. The average CME Group a <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the CME Group a stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.